Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone | Zendy

Diana DíazGarcía | Zendy; Águeda Ferrer-Donato | Zendy; José M. MéndezArriaga | Zendy; Marta Cabrera-Pinto | Zendy; Miguel DíazSánchez | Zendy; Sanjiv Prashar | Zendy; CM Fernandez-Martos | Zendy; Santiago GómezRuiz | Zendy

Open Access

Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone

Author(s) -

Diana DíazGarcía,

Águeda Ferrer-Donato,

José M. MéndezArriaga,

Marta Cabrera-Pinto,

Miguel DíazSánchez,

Sanjiv Prashar,

CM Fernandez-Martos,

Santiago GómezRuiz

Publication year - 2022

Publication title -

acs biomaterials science and engineering

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.082

H-Index - 50

ISSN - 2373-9878

DOI - 10.1021/acsbiomaterials.2c00865

Subject(s) - amyotrophic lateral sclerosis , pioglitazone , mesoporous silica , in vivo , neuroprotection , leptin , nanocarriers , pharmacology , nanomedicine , medicine , drug , disease , type 2 diabetes , chemistry , diabetes mellitus , materials science , nanotechnology , biology , nanoparticle , mesoporous material , endocrinology , obesity , biochemistry , microbiology and biotechnology , catalysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research